Advances in Biomarker Testing in Patients with Sepsis and Bacterial Infections

Unless otherwise noted, P.A.C.E.™ accreditation will expire six months after the live webinar.

Systemic bacterial infections like sepsis and lower respiratory tract infections (LRTI) are often difficult to differentiate from other conditions, which can lead to delays in appropriate treatment or possibly overtreatment. The recent FDA-cleared claim expands procalcitonin (PCT) use to aid clinicians in making antibiotic therapy decisions. This webinar will review case studies that impact antibiotic usage and reduce costs for both patients and healthcare systems.

In this P.A.C.E.™-accredited Fisher HealthCare™ webinar, you will learn how biomarkers like PCT can be used to help guide treatment of systemic bacterial infections and the role that the laboratory plays in helping to direct patient therapy. Register today to see how the recent claim extension of PCT could impact your facility.

This webinar will help you:

• Identify various biomarkers that are used to assess systemic infections
• Discuss the recently cleared claim on how PCT can be used by clinicians for antibiotic stewardship
• Define how PCT provides insight on patient disposition, response to treatment and likelihood of survival
• Discuss the clinical application of PCT using LRTI and sepsis case studies

Watch On Demand    View Slides

This webinar is produced by Whitehat Communications, a provider of continuing education programs in clinical laboratory sciences that has been approved by the ASCLS P.A.C.E. Program. One P.A.C.E. credit hour will be provided for this complimentary, basic-level program.

Eric Gluck, MD, FCCP JD

Dr. Eric Gluck is the Director of Critical Care Services at Swedish Covenant Hospital in Chicago, Illinois and a professor of medicine at both the Finch University of Health Sciences and the Chicago Medical School in North Chicago. He is board certified in internal medicine with subspecialties in pulmonary and critical care medicine.

Dr. Gluck has delivered lectures on pulmonary and critical care medicine (including sepsis and biomarkers) both nationally and internationally. He has used procalcitonin in daily critical care since the FDA cleared its use in the U.S., and has collected and analyzed data for publication in Critical Care Medicine, the American Journal of Respiratory and Critical Care Medicine, and CHEST Journal.